{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:10:52Z","timestamp":1790640652222,"version":"4.1.0"},"reference-count":174,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T00:00:00Z","timestamp":1611014400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T00:00:00Z","timestamp":1611014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s10620-021-06824-7","type":"journal-article","created":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T14:03:01Z","timestamp":1611064981000},"page":"26-41","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["Nonalcoholic Fatty Pancreas Disease: Role in Metabolic Syndrome, \u201cPrediabetes,\u201d Diabetes and Atherosclerosis"],"prefix":"10.1007","volume":"67","author":[{"given":"T. D.","family":"Filippatos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Alexakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Mavrikaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. P.","family":"Mikhailidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,19]]},"reference":[{"key":"6824_CR1","first-page":"1","volume":"219","author":"CL Ogden","year":"2015","unstructured":"Ogden CL, Carroll MD, Fryar CD, Flegal KM. Prevalence of obesity among adults and youth: United States, 2011\u20132014. NCHS Data Brief 2015;219:1\u20138","journal-title":"NCHS Data Brief"},{"key":"6824_CR2","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S2213-8587(19)30084-1","volume":"7","author":"IJ Neeland","year":"2019","unstructured":"Neeland IJ, Ross R, Despr\u00e9s J-P, Matsuzawa Y, Yamashita S, Shai I et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. Lancet Diabetes Endocrinol 2019;7:715\u2013725","journal-title":"Lancet Diabetes Endocrinol"},{"key":"6824_CR3","doi-asserted-by":"crossref","first-page":"432","DOI":"10.2174\/1570161114666160722112738","volume":"14","author":"N Katsiki","year":"2016","unstructured":"Katsiki N, Athyros VG, Mikhailidis DP. Abnormal peri-organ or intra-organ fat (APIFat) deposition: an underestimated predictor of vascular risk? Curr Vasc Pharmacol 2016;14:432\u2013441","journal-title":"Curr Vasc Pharmacol"},{"key":"6824_CR4","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S2213-8587(14)70032-4","volume":"2","author":"H Yki-J\u00e4rvinen","year":"2014","unstructured":"Yki-J\u00e4rvinen H. Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. Lancet Diabetes Endocrinol 2014;2:901\u2013910","journal-title":"Lancet Diabetes Endocrinol"},{"key":"6824_CR5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nrgastro.2011.4","volume":"8","author":"MM Smits","year":"2011","unstructured":"Smits MM, van Geenen EJM. The clinical significance of pancreatic steatosis. Nat Rev Gastroenterol Hepatol 2011;8:169\u2013177","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"6824_CR6","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1097\/MPA.0000000000000941","volume":"46","author":"S Majumder","year":"2017","unstructured":"Majumder S, Philip NA, Takahashi N, Levy MJ, Singh VP, Chari ST. Fatty pancreas: Should we be concerned? Pancreas 2017;46:1251\u20131258","journal-title":"Pancreas"},{"key":"6824_CR7","doi-asserted-by":"crossref","first-page":"87","DOI":"10.14740\/gr731w","volume":"9","author":"H Tariq","year":"2016","unstructured":"Tariq H, Nayudu S, Akella S, Glandt M, Chilimuri S. Non-alcoholic fatty pancreatic disease: a review of literature. Gastroenterol Res 2016;9:87\u201391","journal-title":"Gastroenterol Res"},{"key":"6824_CR8","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2478\/rjim-2019-0005","volume":"57","author":"L Pinte","year":"2019","unstructured":"Pinte L, Balaban DV, B\u0103icu\u015f C, Jinga M. Non-alcoholic fatty pancreas disease\u2014practices for clinicians. Romanian J Intern Med Rev Roum Med Interne 2019;57:209\u2013219","journal-title":"Romanian J Intern Med Rev Roum Med Interne"},{"key":"6824_CR9","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/postgradmedj-2016-134546","volume":"93","author":"T Alempijevic","year":"2017","unstructured":"Alempijevic T, Dragasevic S, Zec S, Popovic D, Milosavljevic T. Non-alcoholic fatty pancreas disease. Postgrad Med J 2017;93:226\u2013230","journal-title":"Postgrad Med J"},{"issue":"Suppl 1","key":"6824_CR10","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1002\/ncp.10397","volume":"34","author":"N Shah","year":"2019","unstructured":"Shah N, Rocha JP, Bhutiani N, Endashaw O. Nonalcoholic fatty pancreas disease. Nutr Clin Pract 2019;34:S49-56","journal-title":"Nutr Clin Pract"},{"key":"6824_CR11","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2174\/1871530318666180328111302","volume":"18","author":"BS Romana","year":"2018","unstructured":"Romana BS, Chela H, Dailey FE, Nassir F, Tahan V. Non-alcoholic fatty pancreas disease (NAFPD): a silent spectator or the fifth component of metabolic syndrome? A literature review. Endocr Metab Immune Disord Drug Targets 2018;18:547\u2013554","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"6824_CR12","first-page":"578","volume":"16","author":"J Zhou","year":"2016","unstructured":"Zhou J, Li M-L, Zhang D-D, Lin H-Y, Dai X-H, Sun X-L et al. The correlation between pancreatic steatosis and metabolic syndrome in a Chinese population. Pancreatol Off J Int Assoc Pancreatol IAP Al 2016;16:578\u2013583","journal-title":"Pancreatol Off J Int Assoc Pancreatol IAP Al"},{"key":"6824_CR13","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12876-015-0404-1","volume":"15","author":"CRA Lesmana","year":"2015","unstructured":"Lesmana CRA, Pakasi LS, Inggriani S, Aidawati ML, Lesmana LA. Prevalence of Non-Alcoholic Fatty Pancreas Disease (NAFPD) and its risk factors among adult medical check-up patients in a private hospital: a large cross sectional study. BMC Gastroenterol 2015;15:174","journal-title":"BMC Gastroenterol"},{"key":"6824_CR14","doi-asserted-by":"crossref","first-page":"e000297","DOI":"10.1161\/JAHA.113.000297","volume":"3","author":"C-Y Wang","year":"2014","unstructured":"Wang C-Y, Ou H-Y, Chen M-F, Chang T-C, Chang C-J. Enigmatic ectopic fat: prevalence of nonalcoholic fatty pancreas disease and its associated factors in a Chinese population. J Am Heart Assoc 2014;3:e000297","journal-title":"J Am Heart Assoc"},{"key":"6824_CR15","doi-asserted-by":"crossref","first-page":"196","DOI":"10.14423\/SMJ.0000000000000432","volume":"109","author":"YH Pham","year":"2016","unstructured":"Pham YH, Bingham BA, Bell CS, Greenfield SA, John SD, Robinson LH et al. Prevalence of pancreatic steatosis at a pediatric tertiary care center. South Med J 2016;109:196\u2013198","journal-title":"South Med J"},{"key":"6824_CR16","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/ca.20543","volume":"20","author":"Y Saisho","year":"2007","unstructured":"Saisho Y, Butler AE, Meier JJ, Monchamp T, Allen-Auerbach M, Rizza RA et al. Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes. Clin Anat N Y N 2007;20:933\u2013942","journal-title":"Clin Anat N Y N"},{"key":"6824_CR17","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/MPA.0b013e318201669f","volume":"40","author":"J Li","year":"2011","unstructured":"Li J, Xie Y, Yuan F, Song B, Tang C. Noninvasive quantification of pancreatic fat in healthy male population using chemical shift magnetic resonance imaging: effect of aging on pancreatic fat content. Pancreas 2011;40:295\u2013299","journal-title":"Pancreas"},{"key":"6824_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.metabol.2016.12.012","volume":"69","author":"RG Singh","year":"2017","unstructured":"Singh RG, Yoon HD, Wu LM, Lu J, Plank LD, Petrov MS. Ectopic fat accumulation in the pancreas and its clinical relevance: A systematic review, meta-analysis, and meta-regression. Metabolism 2017;69:1\u201313","journal-title":"Metabolism"},{"key":"6824_CR19","first-page":"429","volume":"18","author":"PO Coe","year":"2018","unstructured":"Coe PO, Williams SR, Morris DM, Parkin E, Harvie M, Renehan AG et al. Development of MR quantified pancreatic fat deposition as a cancer risk biomarker. Pancreatol Off J Int Assoc Pancreatol IAP Al 2018;18:429\u2013437","journal-title":"Pancreatol Off J Int Assoc Pancreatol IAP Al"},{"key":"6824_CR20","doi-asserted-by":"crossref","first-page":"273","DOI":"10.15557\/JoU.2016.0027","volume":"16","author":"A Smereczy\u0144ski","year":"2016","unstructured":"Smereczy\u0144ski A, Ko\u0142aczyk K. Is a fatty pancreas a banal lesion? J Ultrason 2016;16:273\u2013280","journal-title":"J Ultrason"},{"key":"6824_CR21","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1177\/0284185117745908","volume":"59","author":"F Yuan","year":"2018","unstructured":"Yuan F, Song B, Huang Z, Xia C, Liu X. Quantification of pancreatic fat with dual-echo imaging at 3.0-T MR in clinical application: how do the corrections for T1 and T2* relaxation effect work and simplified correction strategy. Acta Radiol 2018;59:1021\u20131028","journal-title":"Acta Radiol"},{"key":"6824_CR22","doi-asserted-by":"crossref","first-page":"e0224921","DOI":"10.1371\/journal.pone.0224921","volume":"14","author":"S Kato","year":"2019","unstructured":"Kato S, Iwasaki A, Kurita Y, Arimoto J, Yamamoto T, Hasegawa S et al. Three-dimensional analysis of pancreatic fat by fat-water magnetic resonance imaging provides detailed characterization of pancreatic steatosis with improved reproducibility. PLoS ONE 2019;14:e0224921","journal-title":"PLoS ONE"},{"key":"6824_CR23","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/ijo.2014.126","volume":"39","author":"B Gaborit","year":"2015","unstructured":"Gaborit B, Abdesselam I, Kober F, Jacquier A, Ronsin O, Emungania O et al. Ectopic fat storage in the pancreas using 1H-MRS: importance of diabetic status and modulation with bariatric surgery-induced weight loss. Int J Obest 2015;39:480\u2013487","journal-title":"Int J Obest"},{"key":"6824_CR24","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1148\/radiology.137.2.7433680","volume":"137","author":"WM Marks","year":"1980","unstructured":"Marks WM, Filly RA, Callen PW. Ultrasonic evaluation of normal pancreatic echogenicity and its relationship to fat deposition. Radiology 1980;137:475\u2013479","journal-title":"Radiology"},{"key":"6824_CR25","doi-asserted-by":"crossref","first-page":"20180267","DOI":"10.1259\/bjr.20180267","volume":"91","author":"NS Sakai","year":"2018","unstructured":"Sakai NS, Taylor SA, Chouhan MD. Obesity, metabolic disease and the pancreas-quantitative imaging of pancreatic fat. Br J Radiol 2018;91:20180267","journal-title":"Br J Radiol"},{"key":"6824_CR26","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1148\/radiol.13122883","volume":"271","author":"SY Kim","year":"2014","unstructured":"Kim SY, Kim H, Cho JY, Lim S, Cha K, Lee KH et al. Quantitative assessment of pancreatic fat by using unenhanced CT: pathologic correlation and clinical implications. Radiology 2014;271:104\u2013112","journal-title":"Radiology"},{"key":"6824_CR27","first-page":"585","volume":"11","author":"EJ Balthazar","year":"2011","unstructured":"Balthazar EJ. CT contrast enhancement of the pancreas: patterns of enhancement, pitfalls and clinical implications. Pancreatol Off J Int Assoc Pancreatol IAP Al 2011;11:585\u2013587","journal-title":"Pancreatol Off J Int Assoc Pancreatol IAP Al"},{"key":"6824_CR28","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1148\/radiol.13121360","volume":"267","author":"IS Idilman","year":"2013","unstructured":"Idilman IS, Aniktar H, Idilman R, Kabacam G, Savas B, Elhan A et al. Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy. Radiology 2013;267:767\u2013775","journal-title":"Radiology"},{"key":"6824_CR29","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1007\/s00261-015-0385-0","volume":"40","author":"IS Idilman","year":"2015","unstructured":"Idilman IS, Tuzun A, Savas B, Elhan AH, Celik A, Idilman R et al. Quantification of liver, pancreas, kidney, and vertebral body MRI-PDFF in non-alcoholic fatty liver disease. Abdom Imaging 2015;40:1512\u20131519","journal-title":"Abdom Imaging"},{"key":"6824_CR30","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/oby.2009.352","volume":"18","author":"HH Hu","year":"2010","unstructured":"Hu HH, Kim H-W, Nayak KS, Goran MI. Comparison of fat-water MRI and single-voxel MRS in the assessment of hepatic and pancreatic fat fractions in humans. Obes Silver Spring Md 2010;18:841\u2013847","journal-title":"Obes Silver Spring Md"},{"key":"6824_CR31","doi-asserted-by":"crossref","first-page":"129**","DOI":"10.1148\/radiol.15140446","volume":"276","author":"J-P K\u00fchn","year":"2015","unstructured":"K\u00fchn J-P, Berthold F, Mayerle J, V\u00f6lzke H, Reeder SB, Rathmann W et al. Pancreatic steatosis demonstrated at MR imaging in the general population: clinical relevance. Radiology 2015;276:129** \u2013 136","journal-title":"Radiology"},{"key":"6824_CR32","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1097\/MPA.0b013e3181a9d5af","volume":"38","author":"M Al-Haddad","year":"2009","unstructured":"Al-Haddad M, Khashab M, Zyromski N, Pungpapong S, Wallace MB, Scolapio J et al. Risk factors for hyperechogenic pancreas on endoscopic ultrasound: a case-control study. Pancreas 2009;38:672\u2013675","journal-title":"Pancreas"},{"key":"6824_CR33","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.gie.2011.01.015","volume":"73","author":"PS Sepe","year":"2011","unstructured":"Sepe PS, Ohri A, Sanaka S, Berzin TM, Sekhon S, Bennett G et al. A prospective evaluation of fatty pancreas by using EUS. Gastrointest Endosc 2011;73:987\u2013993","journal-title":"Gastrointest Endosc"},{"key":"6824_CR34","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2174\/1570161115666170621075619","volume":"16","author":"N Katsiki","year":"2018","unstructured":"Katsiki N, Perez-Martinez P, Anagnostis P, Mikhailidis DP, Karagiannis A. Is nonalcoholic fatty liver disease indeed the hepatic manifestation of metabolic syndrome? Curr Vasc Pharmacol 2018;16:219\u2013227","journal-title":"Curr Vasc Pharmacol"},{"key":"6824_CR35","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1080\/17474124.2018.1533117","volume":"12","author":"BH Mullish","year":"2018","unstructured":"Mullish BH, Forlano R, Manousou P, Mikhailidis DP. Non-alcoholic fatty liver disease and cardiovascular risk: an update. Expert Rev Gastroenterol Hepatol 2018;12:1175\u20131177","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"6824_CR36","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.metabol.2017.02.014","volume":"71","author":"VG Athyros","year":"2017","unstructured":"Athyros VG, Alexandrides TK, Bilianou H, Cholongitas E, Doumas M, Ganotakis ES et al. The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement. Metabolism 2017;71:17\u201332","journal-title":"Metabolism"},{"key":"6824_CR37","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.3748\/wjg.v16.i16.1993","volume":"16","author":"PE Sijens","year":"2010","unstructured":"Sijens PE, Edens MA, Bakker SJL, Stolk RP. MRI-determined fat content of human liver, pancreas and kidney. World J Gastroenterol 2010;16:1993\u20131998","journal-title":"World J Gastroenterol"},{"key":"6824_CR38","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/apt.12237","volume":"37","author":"NS Patel","year":"2013","unstructured":"Patel NS, Peterson MR, Brenner DA, Heba E, Sirlin C, Loomba R. Association between novel MRI-estimated pancreatic fat and liver histology-determined steatosis and fibrosis in non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2013;37:630\u2013639","journal-title":"Aliment Pharmacol Ther"},{"key":"6824_CR39","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.3748\/wjg.15.1869","volume":"15","author":"JS Lee","year":"2009","unstructured":"Lee JS, Kim SH, Jun DW, Han JH, Jang EC, Park JY et al. Clinical implications of fatty pancreas: correlations between fatty pancreas and metabolic syndrome. World J Gastroenterol 2009;15:1869\u20131875","journal-title":"World J Gastroenterol"},{"key":"6824_CR40","first-page":"263","volume":"18","author":"D Wang","year":"2018","unstructured":"Wang D, Yu X-P, Xiao W-M, Jiao X-P, Wu J, Teng D-L et al. Prevalence and clinical characteristics of fatty pancreas in Yangzhou, China: A cross-sectional study. Pancreatol Off J Int Assoc Pancreatol IAP Al 2018;18:263\u2013268","journal-title":"Pancreatol Off J Int Assoc Pancreatol IAP Al"},{"key":"6824_CR41","doi-asserted-by":"crossref","first-page":"e8060","DOI":"10.1097\/MD.0000000000008060","volume":"96","author":"S Li","year":"2017","unstructured":"Li S, Su L, Lv G, Zhao W, Chen J. Transabdominal ultrasonography of the pancreas is superior to that of the liver for detection of ectopic fat deposits resulting from metabolic syndrome. Medicine (Baltimore) 2017;96:e8060","journal-title":"Medicine (Baltimore)"},{"key":"6824_CR42","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1097\/MPA.0b013e3181f6fce2","volume":"39","author":"E-JM van Geenen","year":"2010","unstructured":"van Geenen E-JM, Smits MM, Schreuder TCMA, van der Peet DL, Bloemena E, Mulder CJJ. Nonalcoholic fatty liver disease is related to nonalcoholic fatty pancreas disease. Pancreas 2010;39:1185\u20131190","journal-title":"Pancreas"},{"key":"6824_CR43","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1007\/s10620-018-5295-x","volume":"64","author":"R Rosenblatt","year":"2019","unstructured":"Rosenblatt R, Mehta A, Snell D, Hissong E, Kierans AS, Kumar S. Ultrasonographic nonalcoholic fatty pancreas is associated with advanced fibrosis in NAFLD: a retrospective analysis. Dig Dis Sci 2019;64:262\u2013268. https:\/\/doi.org\/10.1007\/s10620-018-5295-x.","journal-title":"Dig Dis Sci"},{"key":"6824_CR44","doi-asserted-by":"crossref","first-page":"i2156","DOI":"10.1136\/bmj.i2156","volume":"353","author":"D Aune","year":"2016","unstructured":"Aune D, Sen A, Prasad M, Norat T, Janszky I, Tonstad S et al. BMI and all cause mortality: systematic review and non-linear dose-response meta-analysis of 230 cohort studies with 3.74 million deaths among 30.3 million participants. BMJ 2016;353:i2156","journal-title":"BMJ"},{"key":"6824_CR45","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.mcna.2017.08.006","volume":"102","author":"DH Ryan","year":"2018","unstructured":"Ryan DH, Kahan S. Guideline recommendations for obesity management. Med Clin North Am 2018;102:49\u201363","journal-title":"Med Clin North Am"},{"issue":"Suppl 2","key":"6824_CR46","doi-asserted-by":"crossref","first-page":"S789","DOI":"10.1016\/j.dsx.2017.05.018","volume":"11","author":"TD Filippatos","year":"2017","unstructured":"Filippatos TD, Kyrou I, Georgousopoulou EN, Chrysohoou C, Kouli G-M, Tsigos C et al. Modeling anthropometric indices in relation to 10-year (2002\u20132012) incidence of cardiovascular disease, among apparently healthy individuals: the ATTICA study. Diabetes Metab Syndr 2017;11:S789\u2013S795","journal-title":"Diabetes Metab Syndr"},{"key":"6824_CR47","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1097\/HJH.0000000000001731","volume":"36","author":"V Kotsis","year":"2018","unstructured":"Kotsis V, Tsioufis K, Antza C, Seravalle G, Coca A, Sierra C et al. Obesity and cardiovascular risk: a call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: part B: obesity-induced cardiovascular disease, early prevention strategies and future research directions. J Hypertens 2018;36:1441\u20131455","journal-title":"J Hypertens"},{"key":"6824_CR48","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1097\/HJH.0000000000001730","volume":"36","author":"V Kotsis","year":"2018","unstructured":"Kotsis V, Jordan J, Micic D, Finer N, Leitner DR, Toplak H et al. Obesity and cardiovascular risk: a call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: part A: mechanisms of obesity induced hypertension, diabetes and dyslipidemia and practice guidelines for treatment. J Hypertens 2018;36:1427\u20131440","journal-title":"J Hypertens"},{"key":"6824_CR49","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.2174\/1381612825666190708192134","volume":"25","author":"N Katsiki","year":"2019","unstructured":"Katsiki N, Anagnostis P, Kotsa K, Goulis DG, Mikhailidis DP. Obesity, metabolic syndrome and the risk of microvascular complications in patients with diabetes mellitus. Curr Pharm Des 2019;25:2051\u20132059","journal-title":"Curr Pharm Des"},{"key":"6824_CR50","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/aps.2018.40","volume":"39","author":"N Katsiki","year":"2018","unstructured":"Katsiki N, Mikhailidis DP, Banach M. Leptin, cardiovascular diseases and type 2 diabetes mellitus. Acta Pharmacol Sin 2018;39:1176\u20131188","journal-title":"Acta Pharmacol Sin"},{"key":"6824_CR51","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/MOL.0000000000000431","volume":"28","author":"N Katsiki","year":"2017","unstructured":"Katsiki N, Mantzoros C, Mikhailidis DP. Adiponectin, lipids and atherosclerosis. Curr Opin Lipidol 2017;28:347\u2013354","journal-title":"Curr Opin Lipidol"},{"key":"6824_CR52","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.5114\/amsad.2017.70502","volume":"2","author":"TD Filippatos","year":"2017","unstructured":"Filippatos TD, Liberopoulos E, Georgoula M, Tellis CC, Tselepis AD, Elisaf M. Effects of increased body weight and short-term weight loss on serum PCSK9 levels\u2014a prospective pilot study. Arch Med Sci Atheroscler Dis 2017;2:e46-51","journal-title":"Arch Med Sci Atheroscler Dis"},{"key":"6824_CR53","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2174\/157016110790886956","volume":"8","author":"AM Seifalian","year":"2010","unstructured":"Seifalian AM, Filippatos TD, Joshi J, Mikhailidis DP. Obesity and arterial compliance alterations. Curr Vasc Pharmacol 2010;8:155\u2013168","journal-title":"Curr Vasc Pharmacol"},{"key":"6824_CR54","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/j.1468-1331.2007.01849.x","volume":"14","author":"HJ Milionis","year":"2007","unstructured":"Milionis HJ, Filippatos TD, Derdemezis CS, Kalantzi KJ, Goudevenos J, Seferiadis K et al. Excess body weight and risk of first-ever acute ischaemic non-embolic stroke in elderly subjects. Eur J Neurol 2007;14:762\u2013769","journal-title":"Eur J Neurol"},{"key":"6824_CR55","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2147\/DMSO.S194690","volume":"12","author":"J Pienkowska","year":"2019","unstructured":"Pienkowska J, Brzeska B, Kaszubowski M, Kozak O, Jankowska A, Szurowska E. MRI assessment of ectopic fat accumulation in pancreas, liver and skeletal muscle in patients with obesity, overweight and normal BMI in correlation with the presence of central obesity and metabolic syndrome. Diabetes Metab Syndr Obes 2019;12:623\u2013636","journal-title":"Diabetes Metab Syndr Obes"},{"key":"6824_CR56","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2337\/dc10-0760","volume":"34","author":"KA Le","year":"2011","unstructured":"Le KA, Ventura EE, Fisher JQ, Davis JN, Weigensberg MJ, Punyanitya M et al. Ethnic differences in pancreatic fat accumulation and its relationship with other fat depots and inflammatory markers. Diabetes Care 2011;34:485\u2013490","journal-title":"Diabetes Care"},{"key":"6824_CR57","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.3748\/wjg.v16.i34.4329","volume":"16","author":"CW Choi","year":"2010","unstructured":"Choi CW, Kim GH, Kang DH, Kim HW, Kim DU, Heo J et al. Associated factors for a hyperechogenic pancreas on endoscopic ultrasound. World J Gastroenterol 2010;16:4329\u20134334","journal-title":"World J Gastroenterol"},{"key":"6824_CR58","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1038\/oby.2011.114","volume":"19","author":"AP Rossi","year":"2011","unstructured":"Rossi AP, Fantin F, Zamboni GA, Mazzali G, Rinaldi CA, Del Giglio M et al. Predictors of ectopic fat accumulation in liver and pancreas in obese men and women. Obes Silver Spring 2011;19:1747\u20131754","journal-title":"Obes Silver Spring"},{"key":"6824_CR59","first-page":"748","volume":"35","author":"G Targher","year":"2012","unstructured":"Targher G, Rossi AP, Zamboni GA, Fantin F, Antonioli A, Corzato F et al. Pancreatic fat accumulation and its relationship with liver fat content and other fat depots in obese individuals. J Endocrinol Investig 2012;35:748\u2013753","journal-title":"J Endocrinol Investig"},{"key":"6824_CR60","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.4254\/wjh.v8.i33.1452","volume":"8","author":"N Makino","year":"2016","unstructured":"Makino N, Shirahata N, Honda T, Ando Y, Matsuda A, Ikeda Y et al. Pancreatic hyperechogenicity associated with hypoadiponectinemia and insulin resistance: a Japanese population study. World J Hepatol 2016;8:1452\u20131458","journal-title":"World J Hepatol"},{"key":"6824_CR61","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.tem.2017.01.003","volume":"28","author":"AR Moschen","year":"2017","unstructured":"Moschen AR, Adolph TE, Gerner RR, Wieser V, Tilg H. Lipocalin-2: a master mediator of intestinal and metabolic inflammation. Trends Endocrinol Metab 2017;28:388\u2013397","journal-title":"Trends Endocrinol Metab"},{"key":"6824_CR62","doi-asserted-by":"crossref","first-page":"170117","DOI":"10.1016\/j.peptides.2019.170117","volume":"119","author":"RG Singh","year":"2019","unstructured":"Singh RG, Nguyen NN, Cervantes A, Kim JU, Stuart CE, Petrov MS. Circulating levels of lipocalin-2 are associated with fatty pancreas but not fatty liver. Peptides 2019;119:170117","journal-title":"Peptides"},{"key":"6824_CR63","doi-asserted-by":"crossref","first-page":"6820","DOI":"10.3748\/wjg.v21.i22.6820","volume":"21","author":"VG Athyros","year":"2015","unstructured":"Athyros VG, Tziomalos K, Katsiki N, Doumas M, Karagiannis A, Mikhailidis DP. Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: an update. World J Gastroenterol 2015;21:6820\u20136834","journal-title":"World J Gastroenterol"},{"key":"6824_CR64","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.metabol.2016.05.003","volume":"65","author":"N Katsiki","year":"2016","unstructured":"Katsiki N, Mikhailidis DP, Mantzoros CS. Non-alcoholic fatty liver disease and dyslipidemia: an update. Metabolism 2016;65:1109\u20131123","journal-title":"Metabolism"},{"key":"6824_CR65","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1530\/JOE-17-0018","volume":"234","author":"E Nunez-Duran","year":"2017","unstructured":"Nunez-Duran E, Chanclon B, Sutt S, Real J, Marschall HU, Wernstedt Asterholm I et al. Protein kinase STK25 aggravates the severity of non-alcoholic fatty pancreas disease in mice. J Endocrinol 2017;234:15\u201327","journal-title":"J Endocrinol"},{"key":"6824_CR66","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/dmrr.1073","volume":"26","author":"M Heni","year":"2010","unstructured":"Heni M, Machann J, Staiger H, Schwenzer NF, Peter A, Schick F et al. Pancreatic fat is negatively associated with insulin secretion in individuals with impaired fasting glucose and\/or impaired glucose tolerance: a nuclear magnetic resonance study. Diabetes Metab Res Rev 2010;26:200\u2013205","journal-title":"Diabetes Metab Res Rev"},{"key":"6824_CR67","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/RLI.0b013e31816a88c6","volume":"43","author":"NF Schwenzer","year":"2008","unstructured":"Schwenzer NF, Machann J, Martirosian P, Stefan N, Schraml C, Fritsche A et al. Quantification of pancreatic lipomatosis and liver steatosis by MRI: comparison of in\/opposed-phase and spectral-spatial excitation techniques. Investig Radiol 2008;43:330\u2013337","journal-title":"Investig Radiol"},{"key":"6824_CR68","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/oby.2007.110","volume":"16","author":"KE Pinnick","year":"2008","unstructured":"Pinnick KE, Collins SC, Londos C, Gauguier D, Clark A, Fielding BA. Pancreatic ectopic fat is characterized by adipocyte infiltration and altered lipid composition. Obes Silver Spring 2008;16:522\u2013530","journal-title":"Obes Silver Spring"},{"key":"6824_CR69","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.2337\/dc12-0701","volume":"35","author":"LS Szczepaniak","year":"2012","unstructured":"Szczepaniak LS, Victor RG, Mathur R, Nelson MD, Szczepaniak EW, Tyer N et al. Pancreatic steatosis and its relationship to beta-cell dysfunction in humans: racial and ethnic variations. Diabetes Care 2012;35:2377\u20132383","journal-title":"Diabetes Care"},{"key":"6824_CR70","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s13105-016-0476-6","volume":"72","author":"J Soeda","year":"2016","unstructured":"Soeda J, Mouralidarane A, Cordero P, Li J, Nguyen V, Carter R et al. Maternal obesity alters endoplasmic reticulum homeostasis in offspring pancreas. J Physiol Biochem 2016;72:281\u2013291","journal-title":"J Physiol Biochem"},{"key":"6824_CR71","doi-asserted-by":"crossref","first-page":"e89505","DOI":"10.1371\/journal.pone.0089505","volume":"9","author":"R Carter","year":"2014","unstructured":"Carter R, Mouralidarane A, Soeda J, Ray S, Pombo J, Saraswati R et al. Non-alcoholic fatty pancreas disease pathogenesis: a role for developmental programming and altered circadian rhythms. PLoS ONE 2014;9:e89505","journal-title":"PLoS ONE"},{"key":"6824_CR72","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bbrc.2010.02.057","volume":"394","author":"JA Oben","year":"2010","unstructured":"Oben JA, Patel T, Mouralidarane A, Samuelsson AM, Matthews P, Pombo J et al. Maternal obesity programmes offspring development of non-alcoholic fatty pancreas disease. Biochem Biophys Res Commun 2010;394:24\u201328","journal-title":"Biochem Biophys Res Commun"},{"key":"6824_CR73","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.metabol.2006.02.015","volume":"55","author":"I Gazi","year":"2006","unstructured":"Gazi I, Tsimihodimos V, Filippatos T, Bairaktari E, Tselepis AD, Elisaf M. Concentration and relative distribution of low-density lipoprotein subfractions in patients with metabolic syndrome defined according to the National Cholesterol Education Program criteria. Metabolism 2006;55:885\u2013891","journal-title":"Metabolism"},{"key":"6824_CR74","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11745-008-3251-9","volume":"44","author":"KG Lagos","year":"2009","unstructured":"Lagos KG, Filippatos TD, Tsimihodimos V, Gazi IF, Rizos C, Tselepis AD et al. Alterations in the high density lipoprotein phenotype and HDL-associated enzymes in subjects with metabolic syndrome. Lipids 2009;44:9\u201316","journal-title":"Lipids"},{"key":"6824_CR75","doi-asserted-by":"crossref","first-page":"627","DOI":"10.2174\/15701611113119990131","volume":"12","author":"N Katsiki","year":"2014","unstructured":"Katsiki N, Athyros VG, Karagiannis A, Mikhailidis DP. Characteristics other than the diagnostic criteria associated with metabolic syndrome: an overview. Curr Vasc Pharmacol 2014;12:627\u2013641","journal-title":"Curr Vasc Pharmacol"},{"key":"6824_CR76","doi-asserted-by":"crossref","first-page":"928","DOI":"10.3390\/nu5030928","volume":"5","author":"D Nikolic","year":"2013","unstructured":"Nikolic D, Katsiki N, Montalto G, Isenovic ER, Mikhailidis DP, Rizzo M. Lipoprotein subfractions in metabolic syndrome and obesity: clinical significance and therapeutic approaches. Nutrients 2013;5:928\u2013948","journal-title":"Nutrients"},{"key":"6824_CR77","doi-asserted-by":"crossref","first-page":"880","DOI":"10.2174\/15701611113116660171","volume":"11","author":"MS Kostapanos","year":"2013","unstructured":"Kostapanos MS, Florentin M, Elisaf MS, Mikhailidis DP. Hemostatic factors and the metabolic syndrome. Curr Vasc Pharmacol 2013;11:880\u2013905","journal-title":"Curr Vasc Pharmacol"},{"key":"6824_CR78","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ijcard.2012.01.013","volume":"164","author":"A Gluba","year":"2013","unstructured":"Gluba A, Mikhailidis DP, Lip GY, Hannam S, Rysz J, Banach M. Metabolic syndrome and renal disease. Int J Cardiol 2013;164:141\u2013150","journal-title":"Int J Cardiol"},{"key":"6824_CR79","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.metabol.2012.05.002","volume":"62","author":"P Anagnostis","year":"2013","unstructured":"Anagnostis P, Katsiki N, Adamidou F, Athyros VG, Karagiannis A, Kita M et al. 11beta-Hydroxysteroid dehydrogenase type 1 inhibitors: novel agents for the treatment of metabolic syndrome and obesity-related disorders? Metabolism 2013;62:21\u201333","journal-title":"Metabolism"},{"key":"6824_CR80","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/nutrit\/nux014","volume":"75","author":"P Perez-Martinez","year":"2017","unstructured":"Perez-Martinez P, Mikhailidis DP, Athyros VG, Bullo M, Couture P, Covas MI et al. Lifestyle recommendations for the prevention and management of metabolic syndrome: an international panel recommendation. Nutr Rev 2017;75:307\u2013326","journal-title":"Nutr Rev"},{"key":"6824_CR81","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.amjsurg.2017.02.018","volume":"214","author":"E Laou","year":"2017","unstructured":"Laou E, Milionis H, Petrou A, Arnaoutoglou E, Glantzounis G, Bairaktari E et al. The impact of metabolic syndrome and its components on perioperative outcomes after elective laparotomy\u2014a prospective observational study. Am J Surg 2017;214:831\u2013837","journal-title":"Am J Surg"},{"key":"6824_CR82","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jdiacomp.2015.07.012","volume":"30","author":"VG Athyros","year":"2016","unstructured":"Athyros VG, Mikhailidis DP. High incidence of metabolic syndrome further increases cardiovascular risk in patients with type 2 diabetes, Implications for everyday practice. J Diabetes Complicat 2016;30:9\u201311","journal-title":"J Diabetes Complicat"},{"key":"6824_CR83","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/bja\/aev199","volume":"115","author":"P Tzimas","year":"2015","unstructured":"Tzimas P, Petrou A, Laou E, Milionis H, Mikhailidis DP, Papadopoulos G. Impact of metabolic syndrome in surgical patients: should we bother? Br J Anaesth 2015;115:194\u2013202","journal-title":"Br J Anaesth"},{"key":"6824_CR84","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1177\/1479164115598913","volume":"12","author":"N Katsiki","year":"2015","unstructured":"Katsiki N, Athyros VG, Mikhailidis DP. Metabolic syndrome: Different definitions and gender-specific associations with cardiovascular risk factors. Diab Vasc Res 2015;12:471\u2013472","journal-title":"Diab Vasc Res"},{"key":"6824_CR85","doi-asserted-by":"crossref","first-page":"7660","DOI":"10.3748\/wjg.v22.i34.7660","volume":"22","author":"R Catanzaro","year":"2016","unstructured":"Catanzaro R, Cuffari B, Italia A, Marotta F. Exploring the metabolic syndrome: nonalcoholic fatty pancreas disease. World J Gastroenterol 2016;22:7660\u20137675","journal-title":"World J Gastroenterol"},{"key":"6824_CR86","doi-asserted-by":"crossref","first-page":"e3142","DOI":"10.1002\/dmrr.3142","volume":"35","author":"Y Bi","year":"2019","unstructured":"Bi Y, Wang JL, Li ML, Zhou J, Sun XL. The association between pancreas steatosis and metabolic syndrome: a systematic review and meta-analysis. Diabetes Metab Res Rev 2019;35:e3142","journal-title":"Diabetes Metab Res Rev"},{"key":"6824_CR87","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.2918","author":"RG Singh","year":"2017","unstructured":"Singh RG, Yoon HD, Poppitt SD, Plank LD, Petrov MS. Ectopic fat accumulation in the pancreas and its biomarkers: a systematic review and meta-analysis. Diabetes Metab Res Rev. 2017. https:\/\/doi.org\/10.1002\/dmrr.2918.","journal-title":"Diabetes Metab Res Rev"},{"key":"6824_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.rx.2019.05.010","author":"C Ballester-Valles","year":"2019","unstructured":"Ballester-Valles C, Flores-Mendez J, Delgado-Moraleda J, Ballesteros Martin-Portugues A, Merino-Torres JF, Fornes-Ferrer V et al. Hepatic and pancreatic fat as imaging biomarkers of metabolic syndrome. Radiologia. 2019. https:\/\/doi.org\/10.1016\/j.rx.2019.05.010.","journal-title":"Radiologia"},{"key":"6824_CR89","doi-asserted-by":"crossref","first-page":"e11293","DOI":"10.1097\/MD.0000000000011293","volume":"97","author":"S Weng","year":"2018","unstructured":"Weng S, Zhou J, Chen X, Sun Y, Mao Z, Chai K. Prevalence and factors associated with nonalcoholic fatty pancreas disease and its severity in China. Medicine (Baltimore) 2018;97:e11293","journal-title":"Medicine (Baltimore)"},{"key":"6824_CR90","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1002\/oby.20674","volume":"22","author":"M Cohen","year":"2014","unstructured":"Cohen M, Syme C, Deforest M, Wells G, Detzler G, Cheng HL et al. Ectopic fat in youth: the contribution of hepatic and pancreatic fat to metabolic disturbances. Obes Silver Spring 2014;22:1280\u20131286","journal-title":"Obes Silver Spring"},{"key":"6824_CR91","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1097\/MPG.0b013e318244a685","volume":"54","author":"AB Maggio","year":"2012","unstructured":"Maggio AB, Mueller P, Wacker J, Viallon M, Belli DC, Beghetti M et al. Increased pancreatic fat fraction is present in obese adolescents with metabolic syndrome. J Pediatr Gastroenterol Nutr 2012;54:720\u2013726","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"6824_CR92","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/MPA.0000000000000771","volume":"46","author":"J Staaf","year":"2017","unstructured":"Staaf J, Labmayr V, Paulmichl K, Manell H, Cen J, Ciba I et al. Pancreatic fat is associated with metabolic syndrome and visceral fat but not beta-cell function or body mass index in pediatric obesity. Pancreas 2017;46:358\u2013365","journal-title":"Pancreas"},{"key":"6824_CR93","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1515\/jpem-2018-0315","volume":"32","author":"M Elhady","year":"2019","unstructured":"Elhady M, Elazab A, Bahagat KA, Abdallah NA, Ibrahim GE. Fatty pancreas in relation to insulin resistance and metabolic syndrome in children with obesity. J Pediatr Endocrinol Metab 2019;32:19\u201326","journal-title":"J Pediatr Endocrinol Metab"},{"key":"6824_CR94","doi-asserted-by":"crossref","first-page":"i5953","DOI":"10.1136\/bmj.i5953","volume":"355","author":"Y Huang","year":"2016","unstructured":"Huang Y, Cai X, Mai W, Li M, Hu Y. Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis. BMJ 2016;355:i5953","journal-title":"BMJ"},{"key":"6824_CR95","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1900\/RDS.2016.13.226","volume":"13","author":"TD Filippatos","year":"2016","unstructured":"Filippatos TD, Panagiotakos DB, Georgousopoulou EN, Pitaraki E, Kouli GM, Chrysohoou C et al. Mediterranean diet and 10-year (2002\u20132012) incidence of diabetes and cardiovascular disease in participants with prediabetes: the ATTICA study. Rev Diabet Stud 2016;13:226\u2013235","journal-title":"Rev Diabet Stud"},{"key":"6824_CR96","doi-asserted-by":"crossref","first-page":"788","DOI":"10.5114\/aoms.2013.38671","volume":"9","author":"TD Filippatos","year":"2013","unstructured":"Filippatos TD, Rizos EC, Gazi IF, Lagos K, Agouridis D, Mikhailidis DP et al. Differences in metabolic parameters and cardiovascular risk between American Diabetes Association and World Health Organization definition of impaired fasting glucose in European Caucasian subjects: a cross-sectional study. Arch Med Sci 2013;9:788\u2013795","journal-title":"Arch Med Sci"},{"key":"6824_CR97","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s11745-013-3787-1","volume":"48","author":"TD Filippatos","year":"2013","unstructured":"Filippatos TD, Rizos EC, Tsimihodimos V, Gazi IF, Tselepis AD, Elisaf MS. Small high-density lipoprotein (HDL) subclasses are increased with decreased activity of HDL-associated phospholipase A(2) in subjects with prediabetes. Lipids 2013;48:547\u2013555","journal-title":"Lipids"},{"key":"6824_CR98","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.metabol.2017.12.005","volume":"81","author":"B Nowotny","year":"2018","unstructured":"Nowotny B, Kahl S, Kluppelholz B, Hoffmann B, Giani G, Livingstone R et al. Circulating triacylglycerols but not pancreatic fat associate with insulin secretion in healthy humans. Metabolism 2018;81:113\u2013125","journal-title":"Metabolism"},{"key":"6824_CR99","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1148\/radiol.2018170331","volume":"287","author":"CS Hung","year":"2018","unstructured":"Hung CS, Tseng PH, Tu CH, Chen CC, Liao WC, Lee YC et al. Increased pancreatic echogenicity with US: relationship to glycemic progression and incident diabetes. Radiology 2018;287:853\u2013863","journal-title":"Radiology"},{"key":"6824_CR100","first-page":"68","volume":"67","author":"J Fatima","year":"2019","unstructured":"Fatima J, Gupta N, Karoli R, Chandra A, Jagirdaar S, Arora R et al. Association of sonographically assessed visceral and subcutaneous abdominal fat with insulin resistance in prediabetes. J Assoc Physicians India 2019;67:68\u201370","journal-title":"J Assoc Physicians India"},{"key":"6824_CR101","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejim.2014.11.007","volume":"26","author":"A Uygun","year":"2015","unstructured":"Uygun A, Kadayifci A, Demirci H, Saglam M, Sakin YS, Ozturk K et al. The effect of fatty pancreas on serum glucose parameters in patients with nonalcoholic steatohepatitis. Eur J Intern Med 2015;26:37\u201341","journal-title":"Eur J Intern Med"},{"key":"6824_CR102","doi-asserted-by":"crossref","first-page":"4688","DOI":"10.3748\/wjg.v21.i15.4688","volume":"21","author":"L Pacifico","year":"2015","unstructured":"Pacifico L, Di Martino M, Anania C, Andreoli GM, Bezzi M, Catalano C et al. Pancreatic fat and beta-cell function in overweight\/obese children with nonalcoholic fatty liver disease. World J Gastroenterol 2015;21:4688\u20134695","journal-title":"World J Gastroenterol"},{"key":"6824_CR103","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1097\/MPA.0000000000000349","volume":"44","author":"ZZ Zhao","year":"2015","unstructured":"Zhao ZZ, Xin LL, Xia JH, Yang SL, Chen YX, Li K. Long-term high-fat high-sucrose diet promotes enlarged islets and beta-cell damage by oxidative stress in bama minipigs. Pancreas 2015;44:888\u2013895","journal-title":"Pancreas"},{"key":"6824_CR104","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/MCO.0b013e32833aa1ef","volume":"13","author":"DH van Raalte","year":"2010","unstructured":"van Raalte DH, van der Zijl NJ, Diamant M. Pancreatic steatosis in humans: cause or marker of lipotoxicity? Curr Opin Clin Nutr Metab Care 2010;13:478\u2013485","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"6824_CR105","doi-asserted-by":"crossref","first-page":"e0209448","DOI":"10.1371\/journal.pone.0209448","volume":"13","author":"H Miyake","year":"2018","unstructured":"Miyake H, Sakagami J, Yasuda H, Sogame Y, Kato R, Suwa K et al. Association of fatty pancreas with pancreatic endocrine and exocrine function. PLoS ONE 2018;13:e0209448","journal-title":"PLoS ONE"},{"key":"6824_CR106","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1210\/jc.2010-1722","volume":"96","author":"NJ van der Zijl","year":"2011","unstructured":"van der Zijl NJ, Goossens GH, Moors CC, van Raalte DH, Muskiet MH, Pouwels PJ et al. Ectopic fat storage in the pancreas, liver, and abdominal fat depots: impact on beta-cell function in individuals with impaired glucose metabolism. J Clin Endocrinol Metab 2011;96:459\u2013467","journal-title":"J Clin Endocrinol Metab"},{"key":"6824_CR107","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/MEG.0000000000001059","volume":"30","author":"K Ozturk","year":"2018","unstructured":"Ozturk K, Dogan T, Celikkanat S, Ozen A, Demirci H, Kurt O et al. The association of fatty pancreas with subclinical atherosclerosis in nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol 2018;30:411\u2013417","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"6824_CR108","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1007\/s00125-017-4385-1","volume":"60","author":"F Gerst","year":"2017","unstructured":"Gerst F, Wagner R, Kaiser G, Panse M, Heni M, Machann J et al. Metabolic crosstalk between fatty pancreas and fatty liver: effects on local inflammation and insulin secretion. Diabetologia 2017;60:2240\u20132251","journal-title":"Diabetologia"},{"key":"6824_CR109","doi-asserted-by":"publisher","DOI":"10.1055\/a-0896-8671","author":"BA Jaghutriz","year":"2019","unstructured":"Jaghutriz BA, Wagner R, Heni M, Lehmann R, Machann J, Stefan N et al. Metabolomic characteristics of fatty pancreas. Exp Clin Endocrinol Diabetes. 2019. https:\/\/doi.org\/10.1055\/a-0896-8671.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"6824_CR110","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.metabol.2019.05.005","volume":"97","author":"C Quiclet","year":"2019","unstructured":"Quiclet C, Dittberner N, Gassler A, Stadion M, Gerst F, Helms A et al. Pancreatic adipocytes mediate hypersecretion of insulin in diabetes-susceptible mice. Metabolism 2019;97:9\u201317","journal-title":"Metabolism"},{"key":"6824_CR111","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1177\/0003319719848204","volume":"70","author":"N Katsiki","year":"2019","unstructured":"Katsiki N, Dimitriadis G, Mikhailidis DP. Perirenal adiposity and other excessive intra- and peri-organ fat depots: what is the connection? Angiology 2019;70:581\u2013583","journal-title":"Angiology"},{"key":"6824_CR112","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1177\/0003319718776528","volume":"69","author":"N Katsiki","year":"2018","unstructured":"Katsiki N, Mikhailidis DP. Abnormal peri-organ or intra-organ fat deposition and vascular risk. Angiology 2018;69:841\u2013842","journal-title":"Angiology"},{"key":"6824_CR113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molmet.2019.05.001","volume":"25","author":"F Gerst","year":"2019","unstructured":"Gerst F, Wagner R, Oquendo MB, Siegel-Axel D, Fritsche A, Heni M et al. What role do fat cells play in pancreatic tissue? Mol Metab 2019;25:1\u201310","journal-title":"Mol Metab"},{"key":"6824_CR114","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00535-017-1422-2","volume":"53","author":"H Yamazaki","year":"2018","unstructured":"Yamazaki H, Tauchi S, Kimachi M, Dohke M, Hanawa N, Kodama Y et al. Independent association between prediabetes and future pancreatic fat accumulation: a 5-year Japanese cohort study. J Gastroenterol 2018;53:873\u2013882","journal-title":"J Gastroenterol"},{"key":"6824_CR115","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1161\/CIRCULATIONAHA.116.022194","volume":"133","author":"LCC Wang","year":"2016","unstructured":"Wang LCC, Hess CN, Hiatt WR, Goldfine AB. Clinical update: Cardiovascular disease in diabetes mellitus: Atherosclerotic cardiovascular disease and heart failure in type 2 diabetes mellitus\u2014mechanisms, management, and clinical considerations. Circulation 2016;133:2459\u20132502","journal-title":"Circulation"},{"key":"6824_CR116","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrendo.2017.151","volume":"14","author":"Y Zheng","year":"2018","unstructured":"Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol 2018;14:88\u201398","journal-title":"Nat Rev Endocrinol"},{"key":"6824_CR117","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12933-018-0728-6","volume":"17","author":"TR Einarson","year":"2018","unstructured":"Einarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007\u20132017. Cardiovasc Diabetol 2018;17:83","journal-title":"Cardiovasc Diabetol"},{"key":"6824_CR118","doi-asserted-by":"crossref","first-page":"e024935","DOI":"10.1136\/bmjopen-2018-024935","volume":"9","author":"H Wang","year":"2019","unstructured":"Wang H, Ba Y, Cai RC, Xing Q. Association between diabetes mellitus and the risk for major cardiovascular outcomes and all-cause mortality in women compared with men: a meta-analysis of prospective cohort studies. BMJ Open 2019;9:e024935","journal-title":"BMJ Open"},{"key":"6824_CR119","doi-asserted-by":"crossref","first-page":"566","DOI":"10.2174\/1570161115666170201105425","volume":"15","author":"T Filippatos","year":"2017","unstructured":"Filippatos T, Tsimihodimos V, Pappa E, Elisaf M. Pathophysiology of diabetic dyslipidaemia. Curr Vasc Pharmacol 2017;15:566\u2013575","journal-title":"Curr Vasc Pharmacol"},{"key":"6824_CR120","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/17512433.2017.1263565","volume":"10","author":"TD Filippatos","year":"2017","unstructured":"Filippatos TD, Florentin M, Georgoula M, Elisaf MS. Pharmacological management of diabetic dyslipidemia. Expert Rev Clin Pharmacol 2017;10:187\u2013200","journal-title":"Expert Rev Clin Pharmacol"},{"key":"6824_CR121","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1900\/RDS.2013.10.171","volume":"10","author":"AP Agouridis","year":"2013","unstructured":"Agouridis AP, Rizos CV, Elisaf MS, Filippatos TD. Does combination therapy with statins and fibrates prevent cardiovascular disease in diabetic patients with atherogenic mixed dyslipidemia? Rev Diabet Stud 2013;10:171\u2013190","journal-title":"Rev Diabet Stud"},{"key":"6824_CR122","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14779072.2019.1655919","volume":"17","author":"N Katsiki","year":"2019","unstructured":"Katsiki N, Kotsa K, Athyros VG, Mikhailidis DP. Statin use in patients with diabetes: one drug, multiple benefits. Expert Rev Cardiovasc Ther 2019;17:1\u20132","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"6824_CR123","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1080\/14656566.2017.1351946","volume":"18","author":"N Katsiki","year":"2017","unstructured":"Katsiki N, Purrello F, Tsioufis C, Mikhailidis DP. Cardiovascular disease prevention strategies for type 2 diabetes mellitus. Expert Opin Pharmacother 2017;18:1243\u20131260","journal-title":"Expert Opin Pharmacother"},{"key":"6824_CR124","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1089\/met.2018.0086","volume":"17","author":"G Zsori","year":"2019","unstructured":"Zsori G, Illes D, Ivany E, Kosar K, Holzinger G, Tajti M et al. In new-onset diabetes mellitus, metformin reduces fat accumulation in the liver, but not in the pancreas or pericardium. Metab Syndr Relat Disord 2019;17:289\u2013295","journal-title":"Metab Syndr Relat Disord"},{"key":"6824_CR125","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000505366","volume":"38","author":"P Dite","year":"2020","unstructured":"Dite P, Blaho M, Bojkova M, Jabandziev P, Kunovsky L. Nonalcoholic fatty pancreas disease: clinical consequences. Dig Dis Basel Switz 2020;38:143\u2013149","journal-title":"Dig Dis Basel Switz"},{"key":"6824_CR126","doi-asserted-by":"crossref","first-page":"e62561","DOI":"10.1371\/journal.pone.0062561","volume":"8","author":"HY Ou","year":"2013","unstructured":"Ou HY, Wang CY, Yang YC, Chen MF, Chang CJ. The association between nonalcoholic fatty pancreas disease and diabetes. PLoS ONE 2013;8:e62561","journal-title":"PLoS ONE"},{"key":"6824_CR127","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.2337\/dc16-0074","volume":"39","author":"H Yamazaki","year":"2016","unstructured":"Yamazaki H, Tsuboya T, Katanuma A, Kodama Y, Tauchi S, Dohke M et al. Lack of independent association between fatty pancreas and incidence of type 2 diabetes: 5-year Japanese cohort study. Diabetes Care 2016;39:1677\u20131683","journal-title":"Diabetes Care"},{"key":"6824_CR128","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3164\/jcbn.09-83","volume":"46","author":"JC Fraulob","year":"2010","unstructured":"Fraulob JC, Ogg-Diamantino R, Fernandes-Santos C, Aguila MB, Mandarim-de-Lacerda CA. A mouse model of metabolic syndrome: insulin resistance, fatty liver and non-alcoholic fatty pancreas disease (NAFPD) in C57BL\/6 mice fed a high fat diet. J Clin Biochem Nutr 2010;46:212\u2013223","journal-title":"J Clin Biochem Nutr"},{"key":"6824_CR129","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.13108","author":"C Ishibashi","year":"2019","unstructured":"Ishibashi C, Kozawa J, Hosakawa Y, Yoneda S, Kimura T, Fujita Y et al. Pancreatic fat is related to the longitudinal decrease in the increment of C-peptide in glucagon stimulation test in type 2 diabetes patients. J Diabetes Investig. 2019. https:\/\/doi.org\/10.1111\/jdi.13108.","journal-title":"J Diabetes Investig"},{"key":"6824_CR130","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/jdi.12665","volume":"8","author":"TY Yu","year":"2017","unstructured":"Yu TY, Wang CY. Impact of non-alcoholic fatty pancreas disease on glucose metabolism. J Diabetes Investig 2017;8:735\u2013747","journal-title":"J Diabetes Investig"},{"key":"6824_CR131","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.2337\/diabetes.50.11.2481","volume":"50","author":"JS Harmon","year":"2001","unstructured":"Harmon JS, Gleason CE, Tanaka Y, Poitout V, Robertson RP. Antecedent hyperglycemia, not hyperlipidemia, is associated with increased islet triacylglycerol content and decreased insulin gene mRNA level in Zucker diabetic fatty rats. Diabetes 2001;50:2481\u20132486","journal-title":"Diabetes"},{"key":"6824_CR132","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.bbalip.2009.08.006","volume":"1801","author":"V Poitout","year":"2010","unstructured":"Poitout V, Amyot J, Semache M, Zarrouki B, Hagman D, Fontes G. Glucolipotoxicity of the pancreatic beta cell. Biochim Biophys Acta 2010;1801:289\u2013298","journal-title":"Biochim Biophys Acta"},{"key":"6824_CR133","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1210\/jc.2009-0584","volume":"94","author":"I Lingvay","year":"2009","unstructured":"Lingvay I, Esser V, Legendre JL, Price AL, Wertz KM, Adams-Huet B et al. Noninvasive quantification of pancreatic fat in humans. J Clin Endocrinol Metab 2009;94:4070\u20134076","journal-title":"J Clin Endocrinol Metab"},{"key":"6824_CR134","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3892\/etm.2015.2925","volume":"11","author":"J Chai","year":"2016","unstructured":"Chai J, Liu P, Jin E, Su T, Zhang J, Shi K et al. MRI chemical shift imaging of the fat content of the pancreas and liver of patients with type 2 diabetes mellitus. Exp Ther Med 2016;11:476\u2013480","journal-title":"Exp Ther Med"},{"key":"6824_CR135","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00592-014-0581-3","volume":"51","author":"S Lim","year":"2014","unstructured":"Lim S, Bae JH, Chun EJ, Kim H, Kim SY, Kim KM et al. Differences in pancreatic volume, fat content, and fat density measured by multidetector-row computed tomography according to the duration of diabetes. Acta Diabetol 2014;51:739\u2013748","journal-title":"Acta Diabetol"},{"key":"6824_CR136","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/1753-0407.12589","volume":"10","author":"M Kizilgul","year":"2018","unstructured":"Kizilgul M, Wilhelm JJ, Beilman GJ, Chinnakotla S, Dunn TB, Pruett TL et al. Effect of intrapancreatic fat on diabetes outcomes after total pancreatectomy with islet autotransplantation. J Diabetes 2018;10:286\u2013295","journal-title":"J Diabetes"},{"key":"6824_CR137","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.2337\/dc07-0326","volume":"30","author":"ME Tushuizen","year":"2007","unstructured":"Tushuizen ME, Bunck MC, Pouwels PJ, Bontemps S, van Waesberghe JH, Schindhelm RK et al. Pancreatic fat content and beta-cell function in men with and without type 2 diabetes. Diabetes Care 2007;30:2916\u20132921","journal-title":"Diabetes Care"},{"key":"6824_CR138","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jcjd.2015.04.001","volume":"39","author":"BA Wicklow","year":"2015","unstructured":"Wicklow BA, Griffith AT, Dumontet JN, Venugopal N, Ryner LN, McGavock JM. Pancreatic lipid content is not associated with beta cell dysfunction in youth-onset type 2 diabetes. Can J Diabetes 2015;39:398\u2013404","journal-title":"Can J Diabetes"},{"key":"6824_CR139","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.ejim.2014.10.012","volume":"25","author":"A Di Ciaula","year":"2014","unstructured":"Di Ciaula A, Portincasa P. Fat, epigenome and pancreatic diseases. Interplay and common pathways from a toxic and obesogenic environment. Eur J Intern Med 2014;25:865\u2013873","journal-title":"Eur J Intern Med"},{"key":"6824_CR140","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1038\/ctg.2014.5","volume":"5","author":"M Hori","year":"2014","unstructured":"Hori M, Takahashi M, Hiraoka N, Yamaji T, Mutoh M, Ishigamori R et al. Association of pancreatic fatty infiltration with pancreatic ductal adenocarcinoma. Clin Transl Gastroenterol 2014;5:e53","journal-title":"Clin Transl Gastroenterol"},{"key":"6824_CR141","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8081201","author":"MR Skilton","year":"2019","unstructured":"Skilton MR, Celermajer DS, Cosmi E, Crispi F, Gidding SS, Raitakari OT et al. Natural history of atherosclerosis and abdominal aortic intima-media thickness: rationale, evidence, and best practice for detection of atherosclerosis in the young. J Clin Med. 2019. https:\/\/doi.org\/10.3390\/jcm8081201.","journal-title":"J Clin Med"},{"key":"6824_CR142","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/HCO.0b013e3283605fba","volume":"28","author":"N Katsiki","year":"2013","unstructured":"Katsiki N, Mikhailidis DP, Wierzbicki AS. Epicardial fat and vascular risk: a narrative review. Curr Opin Cardiol 2013;28:458\u2013463","journal-title":"Curr Opin Cardiol"},{"key":"6824_CR143","first-page":"64","volume":"17","author":"N Katsiki","year":"2017","unstructured":"Katsiki N, Mikhailidis DP. Epicardial fat: a novel marker of subclinical atherosclerosis in clinical practice? Anatol J Cardiol 2017;17:64\u201365","journal-title":"Anatol J Cardiol"},{"key":"6824_CR144","first-page":"118","volume":"35","author":"S Kul","year":"2019","unstructured":"Kul S, Karadeniz A, Dursun I, Sahin S, Faruk Cirakoglu O, Rasit Sayin M et al. Non-alcoholic fatty pancreas disease is associated with increased epicardial adipose tissue and aortic intima-media thickness. Acta Cardiol Sin 2019;35:118\u2013125","journal-title":"Acta Cardiol Sin"},{"key":"6824_CR145","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.diabres.2014.09.005","volume":"106","author":"MK Kim","year":"2014","unstructured":"Kim MK, Chun HJ, Park JH, Yeo DM, Baek KH, Song KH et al. The association between ectopic fat in the pancreas and subclinical atherosclerosis in type 2 diabetes. Diabetes Res Clin Pract 2014;106:590\u2013596","journal-title":"Diabetes Res Clin Pract"},{"key":"6824_CR146","doi-asserted-by":"crossref","first-page":"e330","DOI":"10.1016\/j.orcp.2013.05.004","volume":"7","author":"M Matsuda","year":"2013","unstructured":"Matsuda M, Shimomura I. Increased oxidative stress in obesity: implications for metabolic syndrome, diabetes, hypertension, dyslipidemia, atherosclerosis, and cancer. Obes Res Clin Pract 2013;7:e330\u2013e341","journal-title":"Obes Res Clin Pract"},{"key":"6824_CR147","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3109\/10520295.2015.1021380","volume":"90","author":"M Ickin Gulen","year":"2015","unstructured":"Ickin Gulen M, Guven Bagla A, Yavuz O, Hismiogullari AA. Histopathological changes in rat pancreas and skeletal muscle associated with high fat diet induced insulin resistance. Biotech Histochem 2015;90:495\u2013505","journal-title":"Biotech Histochem"},{"key":"6824_CR148","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.2337\/db07-1326","volume":"57","author":"M Kebede","year":"2008","unstructured":"Kebede M, Favaloro J, Gunton JE, Laybutt DR, Shaw M, Wong N et al. Fructose-1,6-bisphosphatase overexpression in pancreatic beta-cells results in reduced insulin secretion: a new mechanism for fat-induced impairment of beta-cell function. Diabetes 2008;57:1887\u20131895","journal-title":"Diabetes"},{"key":"6824_CR149","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1177\/1535370217708188","volume":"242","author":"VA Matheus","year":"2017","unstructured":"Matheus VA, Monteiro L, Oliveira RB, Maschio DA, Collares-Buzato CB. Butyrate reduces high-fat diet-induced metabolic alterations, hepatic steatosis and pancreatic beta cell and intestinal barrier dysfunctions in prediabetic mice. Exp Biol Med Maywood 2017;242:1214\u20131226","journal-title":"Exp Biol Med Maywood"},{"key":"6824_CR150","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0140-6736(17)33102-1","volume":"391","author":"ME Lean","year":"2018","unstructured":"Lean ME, Leslie WS, Barnes AC, Brosnahan N, Thom G, McCombie L et al. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. The Lancet 2018;391:541\u2013551","journal-title":"The Lancet"},{"key":"6824_CR151","unstructured":"Taylor R, Al-Mrabeh A, Hollingsworth K, Lean M, Sattar N, Shaw J. Remission of type 2 diabetes with return of insulin secretory function restores normal pancreas morphology."},{"key":"6824_CR152","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1210\/jc.2014-4236","volume":"100","author":"H Honka","year":"2015","unstructured":"Honka H, Koffert J, Hannukainen JC, Tuulari JJ, Karlsson HK, Immonen H et al. The effects of bariatric surgery on pancreatic lipid metabolism and blood flow. J Clin Endocrinol Metab 2015;100:2015\u20132023","journal-title":"J Clin Endocrinol Metab"},{"key":"6824_CR153","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s00330-018-5611-z","volume":"29","author":"SCN Hui","year":"2019","unstructured":"Hui SCN, Wong SKH, Ai Q, Yeung DKW, Ng EKW, Chu WCW. Observed changes in brown, white, hepatic and pancreatic fat after bariatric surgery: evaluation with MRI. Eur Radiol 2019;29:849\u2013856","journal-title":"Eur Radiol"},{"key":"6824_CR154","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1007\/s00125-018-4627-x","volume":"61","author":"MA Heiskanen","year":"2018","unstructured":"Heiskanen MA, Motiani KK, Mari A, Saunavaara V, Eskelinen JJ, Virtanen KA et al. Exercise training decreases pancreatic fat content and improves beta cell function regardless of baseline glucose tolerance: a randomised controlled trial. Diabetologia 2018;61:1817\u20131828","journal-title":"Diabetologia"},{"key":"6824_CR155","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/dom.12680","volume":"18","author":"A Dutour","year":"2016","unstructured":"Dutour A, Abdesselam I, Ancel P, Kober F, Mrad G, Darmon P et al. Exenatide decreases liver fat content and epicardial adipose tissue in patients with obesity and type 2 diabetes: a prospective randomized clinical trial using magnetic resonance imaging and spectroscopy. Diabetes Obes Metab 2016;18:882\u2013891","journal-title":"Diabetes Obes Metab"},{"key":"6824_CR156","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1185\/030079905X75078","volume":"21","author":"TD Filippatos","year":"2005","unstructured":"Filippatos TD, Kiortsis DN, Liberopoulos EN, Georgoula M, Mikhailidis DP, Elisaf MS. Effect of orlistat, micronised fenofibrate and their combination on metabolic parameters in overweight and obese patients with the metabolic syndrome: the FenOrli study. Curr Med Res Opin 2005;21:1997\u20132006","journal-title":"Curr Med Res Opin"},{"key":"6824_CR157","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.atherosclerosis.2006.07.010","volume":"193","author":"TD Filippatos","year":"2007","unstructured":"Filippatos TD, Gazi IF, Liberopoulos EN, Athyros VG, Elisaf MS, Tselepis AD et al. The effect of orlistat and fenofibrate, alone or in combination, on small dense LDL and lipoprotein-associated phospholipase A2 in obese patients with metabolic syndrome. Atherosclerosis 2007;193:428\u2013437","journal-title":"Atherosclerosis"},{"key":"6824_CR158","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1463-1326.2007.00733.x","volume":"10","author":"TD Filippatos","year":"2008","unstructured":"Filippatos TD, Liberopoulos EN, Kostapanos M, Gazi IF, Papavasiliou EC, Kiortsis DN et al. The effects of orlistat and fenofibrate, alone or in combination, on high-density lipoprotein subfractions and pre-beta1-HDL levels in obese patients with metabolic syndrome. Diabetes Obes Metab 2008;10:476\u2013483","journal-title":"Diabetes Obes Metab"},{"key":"6824_CR159","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1177\/0003319711421341","volume":"63","author":"VG Athyros","year":"2012","unstructured":"Athyros VG, Elisaf MS, Alexandrides T, Achimastos A, Ganotakis E, Bilianou E et al. Long-term impact of multifactorial treatment on new-onset diabetes and related cardiovascular events in metabolic syndrome: a post hoc ATTEMPT analysis. Angiology 2012;63:358\u2013366","journal-title":"Angiology"},{"key":"6824_CR160","doi-asserted-by":"crossref","first-page":"647","DOI":"10.2174\/157016111797484080","volume":"9","author":"VG Athyros","year":"2011","unstructured":"Athyros VG, Ganotakis E, Kolovou GD, Nicolaou V, Achimastos A, Bilianou E et al. Assessing the treatment effect in metabolic syndrome without perceptible diabetes (ATTEMPT): a prospective-randomized study in middle aged men and women. Curr Vasc Pharmacol 2011;9:647\u2013657","journal-title":"Curr Vasc Pharmacol"},{"key":"6824_CR161","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/17512433.2018.1429910","volume":"11","author":"J Rask Larsen","year":"2018","unstructured":"Rask Larsen J, Dima L, Correll CU, Manu P. The pharmacological management of metabolic syndrome. Expert Rev Clin Pharmacol 2018;11:397\u2013410","journal-title":"Expert Rev Clin Pharmacol"},{"key":"6824_CR162","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1007\/s00535-020-01683-x","volume":"55","author":"H Yamazaki","year":"2020","unstructured":"Yamazaki H, Tauchi S, Wang J, Dohke M, Hanawa N, Kodama Y et al. Longitudinal association of fatty pancreas with the incidence of type-2 diabetes in lean individuals: a 6-year computed tomography-based cohort study. J Gastroenterol 2020;55:712\u2013721","journal-title":"J Gastroenterol"},{"key":"6824_CR163","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/MPA.0000000000001252","volume":"48","author":"T Tirkes","year":"2019","unstructured":"Tirkes T, Jeon CY, Li L, Joon AY, Seltman TA, Sankar M et al. Association of pancreatic steatosis with chronic pancreatitis, obesity, and type 2 diabetes mellitus. Pancreas 2019;48:420\u2013426","journal-title":"Pancreas"},{"key":"6824_CR164","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/ajg.2014.1","volume":"109","author":"VW Wong","year":"2014","unstructured":"Wong VW, Wong GL, Yeung DK, Abrigo JM, Kong AP, Chan RS et al. Fatty pancreas, insulin resistance, and beta-cell function: a population study using fat-water magnetic resonance imaging. Am J Gastroenterol 2014;109:589\u2013597","journal-title":"Am J Gastroenterol"},{"key":"6824_CR165","doi-asserted-by":"crossref","first-page":"e1337","DOI":"10.6061\/clinics\/2019\/e1337","volume":"74","author":"S Ahbab","year":"2019","unstructured":"Ahbab S, \u00dcnsal A, Atao\u011flu HE, Can TS, Kaya\u015f D, Sava\u015f Y. Prediabetes and type 2 diabetes are independent risk factors for computed tomography-estimated nonalcoholic fatty pancreas disease. Clin Sao Paulo Braz 2019;74:e1337","journal-title":"Clin Sao Paulo Braz"},{"key":"6824_CR166","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/MEG.0000000000001477","volume":"31","author":"J Xie","year":"2019","unstructured":"Xie J, Xu L, Pan Y, Li P, Liu Y, Pan Y et al. Nonalcoholic fatty pancreas disease is related independently to the severity of acute pancreatitis. Eur J Gastroenterol Hepatol 2019;31:973\u2013978","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"6824_CR167","doi-asserted-by":"crossref","first-page":"588","DOI":"10.5152\/tjg.2018.17696","volume":"29","author":"M Tahtac\u0131","year":"2018","unstructured":"Tahtac\u0131 M, Alg\u0131n O, Karakan T, Y\u00fcrekli \u00d6T, Al\u0131\u015f\u0131k M, K\u00f6seo\u011flu H et al. Can pancreatic steatosis affect exocrine functions of pancreas? Turk J Gastroenterol Off J Turk Soc Gastroenterol 2018;29:588\u2013594","journal-title":"Turk J Gastroenterol Off J Turk Soc Gastroenterol"},{"key":"6824_CR168","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1159\/000507457","volume":"36","author":"V Desai","year":"2020","unstructured":"Desai V, Patel K, Sheth R, Barlass U, Chan Y-M, Sclamberg J et al. Pancreatic fat infiltration is associated with a higher risk of pancreatic ductal adenocarcinoma. Visc Med 2020;36:220\u2013226","journal-title":"Visc Med"},{"key":"6824_CR169","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1245\/s10434-017-5914-3","volume":"24","author":"Y Fukuda","year":"2017","unstructured":"Fukuda Y, Yamada D, Eguchi H, Hata T, Iwagami Y, Noda T et al. CT density in the pancreas is a promising imaging predictor for pancreatic ductal adenocarcinoma. Ann Surg Oncol 2017;24:2762\u20132769","journal-title":"Ann Surg Oncol"},{"key":"6824_CR170","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1158\/1078-0432.CCR-14-2385","volume":"21","author":"V Rebours","year":"2015","unstructured":"Rebours V, Gaujoux S, d\u2019Assignies G, Sauvanet A, Ruszniewski P, L\u00e9vy P et al. Obesity and fatty pancreatic infiltration are risk factors for pancreatic precancerous lesions (panin). Clin Cancer Res Off J Am Assoc Cancer Res 2015;21:3522\u20133528","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"6824_CR171","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1111\/cas.13766","volume":"109","author":"M Takahashi","year":"2018","unstructured":"Takahashi M, Hori M, Ishigamori R, Mutoh M, Imai T, Nakagama H. Fatty pancreas: a possible risk factor for pancreatic cancer in animals and humans. Cancer Sci 2018;109:3013\u20133023","journal-title":"Cancer Sci"},{"key":"6824_CR172","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1097\/MPA.0000000000000159","volume":"43","author":"Y Tomita","year":"2014","unstructured":"Tomita Y, Azuma K, Nonaka Y, Kamada Y, Tomoeda M, Kishida M et al. Pancreatic fatty degeneration and fibrosis as predisposing factors for the development of pancreatic ductal adenocarcinoma. Pancreas 2014;43:1032\u20131041","journal-title":"Pancreas"},{"key":"6824_CR173","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1475-2840-12-77","volume":"12","author":"WC Wu","year":"2013","unstructured":"Wu WC, Wang CY. Association between non-alcoholic fatty pancreatic disease (NAFPD) and the metabolic syndrome: case-control retrospective study. Cardiovasc Diabetol 2013;12:77","journal-title":"Cardiovasc Diabetol"},{"key":"6824_CR174","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/cen.12862","volume":"83","author":"C Della Corte","year":"2015","unstructured":"Della Corte C, Mosca A, Majo F, Lucidi V, Panera N, Giglioni E et al. Nonalcoholic fatty pancreas disease and nonalcoholic fatty liver disease: more than ectopic fat. Clin Endocrinol Oxf 2015;83:656\u2013662","journal-title":"Clin Endocrinol Oxf"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-021-06824-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-021-06824-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-021-06824-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T23:08:49Z","timestamp":1697584129000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-021-06824-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,19]]},"references-count":174,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["6824"],"URL":"https:\/\/doi.org\/10.1007\/s10620-021-06824-7","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,19]]},"assertion":[{"value":"25 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"TDF reports lecture honoraria from Boehringer Ingelheim, Mylan, Astra Zeneca, Lilly, Recordati, Bausch Health, Servier and Innovis. KA and VM report no conflicts of interest. DPM has given talks and attended conferences sponsored by Amgen, Novo Nordisk and Libytec.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}